Govt seeks stakeholder inputs on IPR issues in trade pact with UK indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
BioNTech to build first mRNA manufacturing facility in Singapore
By IANS |
Published on
Mon, May 10 2021 15:33 IST |
6 Views
BioNTech to build first mRNA manufacturing facility in Singapore. Image Source: IANS News
Berlin, May 10 : German biotechnology company BioNTech on Monday announced plans to expand its global footprint to Asia by building its first mRNA manufacturing facility in Singapore.
The Covid vaccine maker will establish its regional headquarters for Southeast Asia in Singapore, later this year, it said in a statement. The facility will be operational as early as 2023, it added.
The fully integrated mRNA manufacturing facility will provide regional and global supply capacity of BioNTech s growing pipeline of mRNA-based product candidates. It will be equipped to produce a range of novel mRNA vaccines and therapeutics for infectious diseases and cancer.
Jaishankar Holds Talks With UK Counterpart On Bilateral Trade, Covid Cooperation
The duo discussed the implementation of the ‘2030 Roadmap’ of the India-UK Enhanced Trade Partnership (ETP) to pave way for a Free Trade Agreement Twitter Outlook Web Bureau 2021-05-07T07:41:42+05:30 Jaishankar Holds Talks With UK Counterpart On Bilateral Trade, Covid Cooperation outlookindia.com 2021-05-07T07:50:34+05:30
Also read
External affairs minister S Jaishankar held discussions with his British counterpart Dominic Raab on Thursday. The duo discussed bilateral ties, Indo-Pacific cooperation, global health challenges and the implementation of the ‘2030 Roadmap’ of the India-UK Enhanced Trade Partnership (ETP) to pave way for a Free Trade Agreement (FTA).
true
India continues its fight against the deadly COVID-19 second wave even as the healthcare system struggles with the overwhelming surge of cases in the second wave.
Choked hospitals, a huge shortage of oxygen, beds, and other medical equipment, and a lack of adequate healthcare workers are forcing companies and startups to think out of the box.
Gurugram-based healthtech startup MyHealthcare with its MyHealthcare Home initiative is doing its bit to help by enabling healthcare workers to monitor COVID-19 patients with mild to moderate symptoms remotely.
Shyatto Raha, Co-founder and CEO of MyHealthcare, said the main challenge in India in the coming weeks will be the availability of doctors to cater to patient needs.
›India, UK to reduce trade barriers infood, medical devices, cut duty on whiskey, auto under trade pact: UKIBC
India, UK to reduce trade barriers infood, medical devices, cut duty on whiskey, auto under trade pact: UKIBC
SECTIONS
India, UK to reduce trade barriers infood, medical devices, cut duty on whiskey, auto under trade pact: UKIBCBy
Share
Synopsis
The two sides had decided earlier this year to launch an ETP to develop a roadmap that would lead to a potential comprehensive free trade agreement( FTA), including considerations on an interim pact on a preferential basis.
Agencies
In the year before the pandemic bilateral trade grew 10% to GBP24 billion.